Your browser doesn't support javascript.
loading
KIR3DL3-HHLA2 and TMIGD2-HHLA2 pathways: The dual role of HHLA2 in immune responses and its potential therapeutic approach for cancer immunotherapy.
Li, Yang; Lv, Chao; Yu, Yang; Wu, Baokang; Zhang, Yizhou; Lang, Qi; Liang, Zhiyun; Zhong, Chongli; Shi, Yu; Han, Shukun; Xu, Feng; Tian, Yu.
Afiliación
  • Li Y; Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang 110004, Liaoning Province, China.
  • Lv C; Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang 110004, Liaoning Province, China.
  • Yu Y; Department of General Surgery, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou 121001, Liaoning Province, China.
  • Wu B; Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang 110004, Liaoning Province, China.
  • Zhang Y; Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang 110004, Liaoning Province, China.
  • Lang Q; Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang 110004, Liaoning Province, China.
  • Liang Z; Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang 110004, Liaoning Province, China.
  • Zhong C; Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang 110004, Liaoning Province, China.
  • Shi Y; The First Clinical College of China Medical University, Shenyang 110001, Liaoning Province, China.
  • Han S; Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang 110004, Liaoning Province, China.
  • Xu F; Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang 110004, Liaoning Province, China.
  • Tian Y; Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang 110004, Liaoning Province, China. Electronic address: yu.tian@cmu.edu.cn.
J Adv Res ; 47: 137-150, 2023 05.
Article en En | MEDLINE | ID: mdl-35933091

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inmunoglobulinas / Neoplasias Límite: Humans Idioma: En Revista: J Adv Res Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Egipto

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inmunoglobulinas / Neoplasias Límite: Humans Idioma: En Revista: J Adv Res Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Egipto